Abstract:Conventional observational epidemiology has an unenviable reputation for generating false-positive findings, or “scares,” as others call them. In 1993, for example, the New York Times reported that “vitamin E greatly reduces the risk of heart disease” following simultaneous publication of 2 observational studies in the New England Journal of Medicine demonstrating that use of vitamin E supplements, even for just a few years, was associated with a substantially lower risk of coronary heart disease (CHD). Randomized controlled trials (RCTs)—testing precisely the same hypothesis—revealed no reduction in risk at all. As I write this, UK news media are reporting that “junk food makes your kids dumb,” in response to a paper reporting that children given a poor diet at age 3 had lower IQ scores 5 years later. In the latter case, however, no RCTs are ever likely to be carried out, and the status of the finding will remain liminal. The ratio of false-positive to false-negative (FP:FN) published findings in traditional epidemiology is very high, John Ioannidis and colleagues argue. But what exactly are “false-positive” findings in the context of conventional observational epidemiology, and how can their prevalence be quantified? My suspicion is that use of vitamin E supplements would—in most contexts—be associated with lower risk of CHD, because of substantial confounding by a myriad of measured and unmeasured factors related to such a socially and behaviorally patterned exposure. The same will apply to children fed on junk food and their later intelligence. The inability to substantially “control” statistically for confounding in many situations—due to measurement error in assessed confounders and omission of others—remains underappreciated. In the sense that these associations do exist, they should perhaps not be called false positives; they are false positives only if they are taken to be indicators of underlying causal effects. Noncausal but replicable observational associations could clearly be of considerable value through prediction of disease risk, and targeting of preventive measures to those who can benefit most. For the holy grail of epidemiology—identifying causes of disease—they are a disappointment, however. A wide range of approaches—from formally comparing associations in contexts where confounding structures differ, utilizing correlates of the exposure under study that are not plausible causes and natural experiments, through to formal instrumental variables methods—offer greater hope for reliable causal inference than plowing on with traditional approaches and keeping the FP:FN ratio high. Ioannidis and colleagues reiterate the low positive predictive value of a nominally “significant” P, something I (along with a generation of epidemiologists, I imagine) first encountered in Michael Oakes’ seminal “Statistical Inference, although (as has been

Duloxetine as an Analgesic in Patients Who Do Not Have Central Sensitivity Undergoing Single-Sitting, Bilateral Total Knee Arthroplasty: A Prospective, Double-Blinded, Randomized, Placebo-Controlled Trial

Effect of Duloxetine on Opioid Use and Pain after Total Knee Arthroplasty: A Triple-Blinded Randomized Controlled Trial

Duloxetine Reduces Pain and Improves Quality of Recovery Following Total Knee Arthroplasty in Centrally Sensitized Patients: A Prospective, Randomized Controlled Study

Duloxetine and Subacute Pain after Knee Arthroplasty when Added to A Multimodal Analgesic Regimen A Randomized, Placebo-Controlled, Triple-Blinded Trial

The analgesic effect and safety of duloxetine in total knee arthroplasty: A systematic review

Analgesic effect of parecoxib sodium and oxycodone for postoperative pain after total knee arthroplasty

Does postoperative low-dose duloxetine provide analgesic effect and lower morphine consumption after primary total knee arthroplasty? A prospective, double-blind, randomized controlled trial

Perioperative Duloxetine in Total Joint Arthroplasty: An Umbrella Review

Additional femoral nerve block analgesia does not reduce the chronic pain after total knee arthroplasty: A retrospective study in patients with knee osteoarthritis.

Postoperative acute pain management with duloxetine as compared to placebo: A systematic review with meta‐analysis of randomized clinical trials

Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib Post Total Knee Arthroplasty in Osteoarthritis Patients (PIPFORCE): a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

Perioperative duloxetine improves postoperative outcomes after anterior talofibular ligament repair for chronic lateral ankle instability for patients with depression: A prospective randomized clinical trial

Duloxetine reduces opioid consumption and pain after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials

Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial.

Effect of periarticular cocktail of analgesia on immediate post-operative clinical outcomes after bilateral simultaneous total knee arthroplasty: a randomized placebo controlled, split-body superiority trial

Comparison of the effects of duloxetine and pregabalin on pain and associated factors in patients with knee osteoarthritis

Duloxetine combined with intra-articular injection versus intra-articular injection alone for pain relief in knee osteoarthritis: a study protocol for a randomised controlled trial

Random allocation in observational data: how small but robust effects could facilitate hypothesis-free causal inference.

The efficacy and safety of intra-articular injection of corticosteroids in multimodal analgesic cocktails in total knee arthroplasty-a historically controlled study

Multimodal Analgesia for Accelerated Rehabilitation after Total Knee Arthroplasty: A Randomized, Double-Blind, Controlled Trial on the Effect of the Co-Application of Local Infiltration Analgesia and Femoral Nerve Block Combined with Dexmedetomidine

Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used Versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials.